Column Group Opportunity III, LP
SEC CIK 1931825 · EDGAR
BoughtSold
Most active insiders at EIKN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Column Group Opportunity III, LP | 10% | $38.12M | — |
| 2 | Wolfe Josh | Dir, 10% | $5.00M | — |
| 3 | Lux Ventures V, L.P. | 10% | $5.00M | — |
| 4 | FRAZIER KENNETH C | Dir | $2.00M | — |
| 5 | Column Group IV GP, LP | 10% | $1.03M | — |
| 6 | Foresite Capital Opportunity Management V, LLC | 10% | $1000.0K | — |
| 7 | PERLMUTTER ROGER M | See remarks, Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-02-09 | 2026-02-06 | EIKN | Eikon Therapeutics, Inc. | Column Group Opportunity III, LP | 10% | P - Purchase | $18.00 | +2.12M | 4.31M | +97% | +$38.12M |
| DMI | 2026-02-09 | 2026-02-06 | EIKN | Eikon Therapeutics, Inc. | Column Group Opportunity III, LP | 10% | C - Cnv Deriv | — | +3.60M | 95.5K | New | — |
| DMI | 2025-03-28 | 2025-03-26 | SRZN | Surrozen, Inc./DE | Column Group Opportunity III, LP | 10% | P - Purchase | $11.60 | +1.03M | 704.3K | New | +$12.00M |
Purchase Sale Sale after option exercise All abbreviations